135 related articles for article (PubMed ID: 7510813)
21. Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.
Schmitz N; Dreger P; Zander AR; Ehninger G; Wandt H; Fauser AA; Kolb HJ; Zumsprekel A; Martin A; Hecht T
Bone Marrow Transplant; 1995 Feb; 15(2):261-6. PubMed ID: 7539668
[TBL] [Abstract][Full Text] [Related]
22. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle.
Blaise D; Kuentz M; Fortanier C; Bourhis JH; Milpied N; Sutton L; Jouet JP; Attal M; Bordigoni P; Cahn JY; Boiron JM; Schuller MP; Moatti JP; Michallet M
J Clin Oncol; 2000 Feb; 18(3):537-46. PubMed ID: 10653869
[TBL] [Abstract][Full Text] [Related]
23. Low-dose lenograstim is as effective as standard dose in shortening neutrophil engraftment time following myeloablative chemotherapy and peripheral blood progenitor cell rescue.
Nolan L; Lorigan P; Chilton S; Newman J; Else R; Smith P; Linch D; Sweetenham JW; Johnson PW
Br J Haematol; 2007 Jun; 137(5):436-42. PubMed ID: 17433027
[TBL] [Abstract][Full Text] [Related]
24. Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation.
Linch DC; Scarffe H; Proctor S; Chopra R; Taylor PR; Morgenstern G; Cunningham D; Burnett AK; Cawley JC; Franklin IM
Bone Marrow Transplant; 1993 Apr; 11(4):307-11. PubMed ID: 7683552
[TBL] [Abstract][Full Text] [Related]
25. Lenograstim for the treatment of neutropenia in patients receiving ganciclovir for cytomegalovirus infection: a randomised, placebo-controlled trial in AIDS patients.
Dubreuil-Lemaire ML; Gori A; Vittecoq D; Panelatti G; Tharaux F; Palisses R; Gharakhanian S; Rozenbaum W;
Eur J Haematol; 2000 Nov; 65(5):337-43. PubMed ID: 11092465
[TBL] [Abstract][Full Text] [Related]
26. Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies.
Stahel RA; Jost LM; Cerny T; Pichert G; Honegger H; Tobler A; Jacky E; Fey M; Platzer E
J Clin Oncol; 1994 Sep; 12(9):1931-8. PubMed ID: 7521907
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of lenograstim on hematologic tolerance to MAID chemotherapy in patients with advanced soft tissue sarcoma and consequences on treatment dose-intensity.
Bui BN; Chevallier B; Chevreau C; Krakowski I; Peny AM; Thyss A; Maugard-Louboutin C; Cupissol D; Fargeot P; Bonichon F
J Clin Oncol; 1995 Oct; 13(10):2629-36. PubMed ID: 7595717
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of recombinant human granulocyte colony-stimulating factor in children undergoing bone marrow transplantation.
Dini G; Floris R; Pession A; Manfredini L; Dallorso S; Lanino E; Garaventa A; Miano M; Kotitsa Z; Rondelli R
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():121-8. PubMed ID: 8932813
[TBL] [Abstract][Full Text] [Related]
29. GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation.
Greenberg P; Advani R; Keating A; Gulati SC; Nimer S; Champlin R; Karanes C; Gorin NC; Powles RL; Smith A; Lamborn K; Cuffie C
Bone Marrow Transplant; 1996 Dec; 18(6):1057-64. PubMed ID: 8971373
[TBL] [Abstract][Full Text] [Related]
30. [Hematopoietic growth factor (GM-CSF) after autologous bone marrow transplantation. A randomized, double-blind, multicenter study in 91 cases of non-Hodgkin's malignant lymphomas].
Gorin NC; Coiffier B; Hayat M; Fouillard L; Kuentz M; Flesch M; Colombat P; Boivin P; Slavin S; Lemarié JC
Presse Med; 1993 Jan; 22(3):109-20. PubMed ID: 8493215
[TBL] [Abstract][Full Text] [Related]
31. Pegfilgrastim compared to lenograstim after allogeneic peripheral blood stem-cell transplantation from unrelated donors.
Ocheni S; Zabelina T; Bacher U; Ayuk F; Zander A; Kröger N
Leuk Lymphoma; 2009 Apr; 50(4):612-8. PubMed ID: 19263295
[TBL] [Abstract][Full Text] [Related]
32. A randomized, crossover comparison of standard-dose versus low-dose lenograstim in the prophylaxis of post-chemotherapy neutropenia.
Juan O; Campos JM; Carañana V; Sanchez JJ; Casañ R; Alberola V
Support Care Cancer; 2001 Jun; 9(4):241-6. PubMed ID: 11430419
[TBL] [Abstract][Full Text] [Related]
33. Randomized placebo-controlled trial of granulocyte colony stimulating factor (G-CSF) as supportive care after induction chemotherapy in adult patients with acute myeloid leukaemia: a study of the United Kingdom Medical Research Council Adult Leukaemia Working Party.
Wheatley K; Goldstone AH; Littlewood T; Hunter A; Burnett AK
Br J Haematol; 2009 Jun; 146(1):54-63. PubMed ID: 19438472
[TBL] [Abstract][Full Text] [Related]
34. Recombinant human granulocyte colony-stimulating factor attenuates inflammatory responses in septic patients with neutropenia.
Ishikawa K; Tanaka H; Matsuoka T; Shimazu T; Yoshioka T; Sugimoto H
J Trauma; 1998 Jun; 44(6):1047-54; discussion 1054-5. PubMed ID: 9637161
[TBL] [Abstract][Full Text] [Related]
35. Treatment with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation for glycogen storage disease type Ib.
Lachaux A; Boillot O; Stamm D; Canterino I; Dumontet C; Regnier F; Floret D; Hermier M
J Pediatr; 1993 Dec; 123(6):1005-8. PubMed ID: 7693904
[TBL] [Abstract][Full Text] [Related]
36. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates engraftment kinetics after allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia.
Madero L; Díaz MA; Ortega JJ; Olive T; Martínez A; Badell I; Muñoz A; Gómez P
Haematologica; 1999 Feb; 84(2):133-7. PubMed ID: 10091411
[TBL] [Abstract][Full Text] [Related]
37. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
[TBL] [Abstract][Full Text] [Related]
38. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
Cernelc P; Andoljsek D; Mlakar U; Pretnar J; Modic M; Zupan IP; Zver S
Pflugers Arch; 2000; 440(5 Suppl):R81-2. PubMed ID: 11005621
[TBL] [Abstract][Full Text] [Related]
39. Lenograstim administration to HLA-identical donor-recipient pairs to accelerate marrow recovery post-transplant.
Atkinson K; Fay K; Nivison-Smith I; Downs K
Bone Marrow Transplant; 1997 Jan; 19(1):15-21. PubMed ID: 9012926
[TBL] [Abstract][Full Text] [Related]
40. Biosimilar granulocyte colony-stimulating factor is effective in reducing the duration of neutropenia after autologous peripheral blood stem cell transplantation.
Cioch M; Jawniak D; Kotwica K; Wach M; Mańko J; Gorący A; Klimek P; Mazurkiewicz E; Jarosz P; Hus M
Transplant Proc; 2014 Oct; 46(8):2882-4. PubMed ID: 25380941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
